Tchaikapharma High Quality Medicines AD

BUL:THQM Stock Report

Market Cap: лв1.6b

Tchaikapharma High Quality Medicines AD Past Earnings Performance

Past criteria checks 5/6

Tchaikapharma High Quality Medicines AD has been growing earnings at an average annual rate of 31.4%, while the Pharmaceuticals industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 6.9% per year. Tchaikapharma High Quality Medicines AD's return on equity is 4.6%, and it has net margins of 9.5%.

Key information

31.4%

Earnings growth rate

27.1%

EPS growth rate

Pharmaceuticals Industry Growth12.4%
Revenue growth rate6.9%
Return on equity4.6%
Net Margin9.5%
Last Earnings Update31 Dec 2024

Recent past performance updates

Recent updates

Is Tchaikapharma High Quality Medicines AD (BUL:7TH) A Risky Investment?

Jan 20
Is Tchaikapharma High Quality Medicines AD (BUL:7TH) A Risky Investment?

Can You Imagine How Elated Tchaikapharma High Quality Medicines AD's (BUL:7TH) Shareholders Feel About Its 317% Share Price Gain?

Dec 10
Can You Imagine How Elated Tchaikapharma High Quality Medicines AD's (BUL:7TH) Shareholders Feel About Its 317% Share Price Gain?

Revenue & Expenses Breakdown

How Tchaikapharma High Quality Medicines AD makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BUL:THQM Revenue, expenses and earnings (BGN Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2453590
30 Sep 24503430
30 Jun 24492380
31 Mar 24483330
31 Dec 23493280
30 Sep 23504250
30 Jun 23464240
31 Mar 23443240
31 Dec 22433240
30 Sep 2240160
30 Jun 2243160
31 Mar 2242060
31 Dec 2142160
30 Sep 2142060
30 Jun 2141050
31 Mar 2143150
31 Dec 2040050
30 Sep 2039250
30 Jun 2038140
31 Mar 2036140
31 Dec 1935340
30 Sep 1939940
30 Jun 19381140
31 Mar 19381140
31 Dec 18381140
30 Sep 18351040
30 Jun 18351040
31 Mar 1835940
31 Dec 1733940
30 Sep 1734740
30 Jun 1733840
31 Mar 1732930
31 Dec 1633930
30 Sep 1632930
30 Jun 1632830
31 Mar 1631830
31 Dec 1530840
30 Sep 1533740
30 Jun 1532750
31 Mar 1530750
31 Dec 1429750

Quality Earnings: THQM has high quality earnings.

Growing Profit Margin: THQM's current net profit margins (9.5%) are higher than last year (7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: THQM's earnings have grown significantly by 31.4% per year over the past 5 years.

Accelerating Growth: THQM's earnings growth over the past year (48.3%) exceeds its 5-year average (31.4% per year).

Earnings vs Industry: THQM earnings growth over the past year (48.3%) exceeded the Pharmaceuticals industry 11.4%.


Return on Equity

High ROE: THQM's Return on Equity (4.6%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/05 14:36
End of Day Share Price 2025/02/05 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Tchaikapharma High Quality Medicines AD is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.